FYTTD1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
plasmacytoid dendritic cell	17 studies	28% ± 10%	Explore
natural killer cell	16 studies	20% ± 3%	Explore
endothelial cell	10 studies	27% ± 8%	Explore
B cell	9 studies	21% ± 3%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	25% ± 4%	Explore
CD16-positive, CD56-dim natural killer cell, human	9 studies	20% ± 3%	Explore
macrophage	9 studies	22% ± 4%	Explore
fibroblast	9 studies	23% ± 5%	Explore
smooth muscle cell	8 studies	19% ± 5%	Explore
memory B cell	8 studies	21% ± 4%	Explore
pericyte	8 studies	19% ± 3%	Explore
gamma-delta T cell	8 studies	21% ± 6%	Explore
conventional dendritic cell	7 studies	22% ± 8%	Explore
naive B cell	6 studies	23% ± 3%	Explore
mature NK T cell	6 studies	17% ± 1%	Explore
mucosal invariant T cell	6 studies	18% ± 3%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	18% ± 2%	Explore
dendritic cell	6 studies	33% ± 13%	Explore
endothelial cell of lymphatic vessel	5 studies	18% ± 3%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	5 studies	18% ± 1%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	5 studies	17% ± 1%	Explore
epithelial cell	5 studies	33% ± 13%	Explore
oligodendrocyte	5 studies	20% ± 3%	Explore
classical monocyte	4 studies	23% ± 7%	Explore
non-classical monocyte	4 studies	25% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	4 studies	18% ± 1%	Explore
myofibroblast cell	4 studies	19% ± 2%	Explore
precursor B cell	4 studies	23% ± 3%	Explore
basal cell	4 studies	24% ± 8%	Explore
innate lymphoid cell	4 studies	21% ± 3%	Explore
GABAergic neuron	4 studies	32% ± 10%	Explore
glutamatergic neuron	4 studies	43% ± 12%	Explore
mast cell	3 studies	24% ± 6%	Explore
hematopoietic precursor cell	3 studies	22% ± 10%	Explore
leukocyte	3 studies	20% ± 1%	Explore
CD4-positive, alpha-beta T cell	3 studies	20% ± 4%	Explore
myeloid cell	3 studies	31% ± 9%	Explore
pro-B cell	3 studies	28% ± 7%	Explore
retinal cone cell	3 studies	36% ± 12%	Explore
ciliated cell	3 studies	29% ± 3%	Explore
germinal center B cell	3 studies	23% ± 6%	Explore
regulatory T cell	3 studies	18% ± 1%	Explore
CD8-positive, alpha-beta T cell	3 studies	16% ± 0%	Explore
endothelial cell of vascular tree	3 studies	16% ± 1%	Explore
group 3 innate lymphoid cell	3 studies	27% ± 11%	Explore
neuron	3 studies	33% ± 11%	Explore
hematopoietic stem cell	3 studies	18% ± 2%	Explore
double negative thymocyte	3 studies	25% ± 8%	Explore
astrocyte	3 studies	25% ± 4%	Explore
CD4-positive, alpha-beta memory T cell	3 studies	21% ± 5%	Explore
oligodendrocyte precursor cell	3 studies	24% ± 2%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
lung	7 studies	22% ± 6%	Explore
peripheral blood	7 studies	21% ± 6%	Explore
brain	6 studies	30% ± 8%	Explore
eye	3 studies	23% ± 5%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
breast	100%	4063.51	459 / 459	100%	44.83	1118 / 1118
esophagus	100%	4484.27	1445 / 1445	100%	46.26	183 / 183
ovary	100%	3931.18	180 / 180	100%	33.65	430 / 430
uterus	100%	4314.81	170 / 170	100%	43.05	459 / 459
lung	100%	3871.06	577 / 578	100%	42.49	1155 / 1155
thymus	100%	3312.70	653 / 653	100%	32.68	603 / 605
brain	100%	2795.99	2633 / 2642	100%	33.92	705 / 705
prostate	100%	3532.67	245 / 245	100%	32.15	500 / 502
bladder	100%	4458.67	21 / 21	99%	32.60	501 / 504
pancreas	100%	2618.58	328 / 328	99%	26.79	176 / 178
intestine	100%	4074.28	966 / 966	98%	23.76	519 / 527
kidney	100%	2785.69	89 / 89	98%	26.74	887 / 901
stomach	100%	2766.45	359 / 359	98%	24.92	280 / 286
adrenal gland	100%	3004.45	258 / 258	96%	18.04	221 / 230
skin	100%	4527.75	1808 / 1809	94%	29.07	446 / 472
liver	100%	2025.28	226 / 226	91%	12.73	370 / 406
adipose	100%	4446.20	1204 / 1204	0%	0	0 / 0
blood vessel	100%	4892.90	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	37.24	29 / 29
muscle	100%	8095.61	803 / 803	0%	0	0 / 0
spleen	100%	3115.77	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	50.46	45 / 45
ureter	0%	0	0 / 0	100%	20.12	1 / 1
heart	99%	3680.40	850 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	74%	10.09	59 / 80
peripheral blood	72%	2368.15	668 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0006406	Biological process	mRNA export from nucleus
GO_0016607	Cellular component	nuclear speck
GO_0005654	Cellular component	nucleoplasm
GO_0005515	Molecular function	protein binding
GO_0003729	Molecular function	mRNA binding
GO_0003723	Molecular function	RNA binding

IV. Literature review

[source]

Gene name	FYTTD1
Protein name	Forty-two-three domain containing 1 UAP56-interacting factor (Forty-two-three domain-containing protein 1) UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3)
Synonyms	UIF
Description	FUNCTION: Required for mRNA export from the nucleus to the cytoplasm. Acts as an adapter that uses the DDX39B/UAP56-NFX1 pathway to ensure efficient mRNA export and delivering to the nuclear pore. Associates with spliced and unspliced mRNAs simultaneously with ALYREF/THOC4. .
Accessions	ENST00000426031.5 H9KVD1 H9KVC1 ENST00000241502.9 [Q96QD9-1] ENST00000412924.5 ENST00000424384.2 [Q96QD9-3] H9KVD5 ENST00000428738.5 ENST00000494309.5 H9KVC6 ENST00000415708.6 [Q96QD9-2] Q96QD9 ENST00000418169.5 [Q96QD9-4]

FYTTD1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review